title: Bis-imidazolinylindoles are active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Mycobacterium tuberculosis.
authors.affiliation: Target Discovery and Experimental Microbiology Department, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA. rekha.panchal@amedd.army.mil
authors.forename: Rekha G
authors.initials: RG
authors.lastname: Panchal
authors.forename: Douglas
authors.initials: D
authors.lastname: Lane
authors.forename: Helena I
authors.initials: HI
authors.lastname: Boshoff
authors.forename: Michelle M
authors.initials: MM
authors.lastname: Butler
authors.forename: Donald T
authors.initials: DT
authors.lastname: Moir
authors.forename: Terry L
authors.initials: TL
authors.lastname: Bowlin
authors.forename: Sina
authors.initials: S
authors.lastname: Bavari
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018432:Drug Resistance, Multiple; D048289:Imidazolidines / Q000494:pharmacology*; D007211:Indoles / Q000494:pharmacology*; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D051379:Mice; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D048289:Imidazolidines; D007211:Indoles